FK 506 and deoxyspergualin: additive immunosuppressive effect on rat cardiac allograft rejection in vivo and mitogen-stimulated human lymphocyte responses in vitro.
Jiang
H
H
Department of Urology, Osaka University Hospital, Japan.
Takahara
S
S
Li
D
D
Namiki
M
M
Ishibashi
M
M
Okuyama
A
A
Sonoda
T
T
D000818:Animals; D002478:Cells, Cultured; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D006146:Guanidines / Q000494:pharmacology* / Q000627:therapeutic use; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008934:Mitogens; D016853:Muromonab-CD3 / Q000494:pharmacology; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000494:pharmacology* / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014185:Transplantation, Isogeneic
D006146:Guanidines; D007166:Immunosuppressive Agents; D008934:Mitogens; D016853:Muromonab-CD3; C037258:gusperimus; D016559:Tacrolimus